ZBTB11
protein-codingzinc finger and BTB domain containing 11, the group of Zinc fingers C2H2-type|BTB domain containing
Gene summary
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of DNA-templated transcription. Located in nucleoplasm. Implicated in autosomal recessive intellectual developmental disorder 69. [provided by Alliance of Genome Resources, Jul 2025]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~28.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032715
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0032715
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0032715
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0800439
Submitter: ClinGen
*ZBTB11* was first reported in relation to autosomal recessive syndromic complex neurodevelopmental disorder in 1995 (Stromme et al., PMID: 7586637). The condition is regressive, with phenotypes usually presenting around three to five years of age and increasing in severity through life. Intellectual disability (ranging from mild to profound), along with other features, such as contractures, coordination problems, cataracts, and combined malonic and methylmalonic aciduria (CMAMMA) are common phenotypes across affected individuals. Nineteen variants (14 missense, 1 nonsense, and 4 small deletion/duplications leading to frameshift) that have been reported in 13 probands in four publications (PMIDs: 29893856, 31130284, 35104841, 38899514) are included in this curation. All de novo and unknown inheritance variants are within the C2H2 zinc finger domain. The mechanism of pathogenicity appears to be loss of function due to reduced binding to transcriptional targets (PMIDs: 35104841, 38355937). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. This gene-disease relationship is also supported by animal models and functional expression studies (PMID: 29893856). Other members of the ZBTB gene family (*ZBTB18, ZBTB20*) have previously been associated with intellectual disability and similar syndromic disorders (PMIDs: 24193349, 25017102), however intellectual disability and/or autism in these genes are associated with autosomal dominant inheritance. In summary, there is definitive evidence supporting the relationship between *ZBTB11* and autosomal recessive syndromic complex neurodevelopmental disorder. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism GCEP on the meeting date June 2, 2026 (SOP Version 12).
Inheritance Pattern: AR
Disease ID:MONDO:0032715
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ZBTB11 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_014415.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 29 | 29 | ||||
| missense | 7 | 118 | 7 | 132 | ||
| nonsense | 2 | 5 | 7 | |||
| start loss | 0 | |||||
| frameshift | 2 | 2 | 4 | |||
| splice donor/acceptor (+/-2bp) | 5 | 5 | ||||
| Total | 11 | 0 | 130 | 36 | 0 | 177 |
Highest pathogenic variant AF is 0.000005580959
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055230.2 | 11 | MANE Select | |
| Ensembl | ENSP00000326200.4 | 11 | MANE Select | |
| Ensembl | ENSP00000417369.1 | 2 | Standard | |
| Ensembl | ENSP00000417369.1 | 2 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- regulation of transcription by RNA polymerase II
- biological_process
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- molecular_function
- DNA binding
- metal ion binding
Cellular Component
- nucleoplasm
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000312938
- Coding exons
- 11
- Length
- 28607
- Individuals with no LoFs
- 125709
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 39
- Defined
- 125748
- p
- 0.000155
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.05 | 424 | 560 | 0.757 | 0.0000282 | 6858 |
| Missense (PolyPhen) | 149 | 255.03 | 0.58425 | 3058 | ||
| Synonymous | -1.66 | 232 | 202 | 1.15 | 0.0000100 | 2003 |
| Loss of Function | 4.20 | 19 | 51.5 | 0.369 | 0.00000303 | 622 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.000089 | 0.000087 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.00022 | 0.00022 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00021 | 0.00020 | rare |
| South Asian | 0.00016 | 0.00016 | rare |
| Other | 0.00017 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May be involved in transcriptional regulation.;
Recessive Scores
- pRec
- 0.126
Intolerance Scores
- LoFtool
- 0.641
- RVIS EVS
- -1.3
- RVIS percentile EVS
- 4.92
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.940
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |